LY2140023 (LY404039)

From Aaushi
Jump to navigation Jump to search

Indications

Pharmacokinetics

Mechanism of action

More general terms

References

  1. Patil ST et al Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized phase 2 clinical trial. Nat Med 2007 Sep; 13:1102. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17767166
    Weinberger DR. Schizophrenia drug says goodbye to dopamine. Nat Med 2007 Sep; 13:1018. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17828217